Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited ... - PR Newswire (press release)

Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited ... PR Newswire (press release), NY In June 2005, ACTEMRA was launched by Chugai in Japan as a therapy for Castleman's disease; in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also ...

ACTEMRA(R) (tocilizumab) Studies to be Featured at the European ... - PR Newswire (press release)

ACTEMRA(R) (tocilizumab) Studies to be Featured at the European ... PR Newswire (press release), NY In June 2005, ACTEMRA was launched by Chugai in Japan as a therapy for Castleman's disease; in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also ...

ACTEMRA (tocilizumab) Studies to be Featured at the European ... - PharmaLive.com (press release)

ACTEMRA (tocilizumab) Studies to be Featured at the European ... PharmaLive.com (press release), PA In June 2005, ACTEMRA was launched by Chugai in Japan as a therapy for Castleman's disease; in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also ...

Earlier Methotrexate Treatment Important for Juvenile Arthritis - AAP Grand Rounds (registration)

Earlier Methotrexate Treatment Important for Juvenile Arthritis AAP Grand Rounds (registration), IL 2009;61(1):46–51; doi:10.1002/art24087[CrossRef][Medline] Question: Among children with juvenile idiopathic arthritis, what factors influence response to methotrexate treatment? Researchers from four pediatric rheumatology referral centers in The ...